News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,366 Results
Type
Article (41711)
Company Profile (326)
Press Release (660329)
Section
Business (210075)
Career Advice (2069)
Deals (36565)
Drug Delivery (94)
Drug Development (82759)
Employer Resources (171)
FDA (16473)
Job Trends (15347)
News (355287)
Policy (33810)
Tag
Academia (2574)
Alliances (51032)
Alzheimer's disease (1227)
Approvals (16391)
Artificial intelligence (122)
Bankruptcy (362)
Best Places to Work (11590)
Biotechnology (210)
Breast cancer (102)
Cancer (898)
Career advice (1734)
Cell therapy (194)
Clinical research (65398)
Collaboration (322)
Compensation (157)
COVID-19 (2591)
Cystic fibrosis (80)
Data (829)
Diabetes (128)
Diagnostics (6173)
Drug pricing (85)
Earnings (85735)
Employer resources (148)
Events (111570)
Executive appointments (245)
FDA (16904)
Funding (284)
Gene therapy (156)
GLP-1 (586)
Government (4435)
Healthcare (18828)
Infectious disease (2663)
Inflammatory bowel disease (105)
Interviews (319)
IPO (16540)
Job creations (4049)
Job search strategy (1485)
Layoffs (427)
Legal (8311)
Lung cancer (155)
Manufacturing (154)
Medical device (13221)
Medtech (13226)
Mergers & acquisitions (20021)
Metabolic disorders (362)
Neuroscience (1471)
NextGen Class of 2024 (6618)
Non-profit (4510)
Northern California (1169)
Obesity (217)
Opinion (199)
Patents (96)
People (58054)
Pharmaceutical (92)
Phase I (20199)
Phase II (28764)
Phase III (21616)
Pipeline (201)
Postmarket research (2643)
Preclinical (8607)
Radiopharmaceuticals (239)
Rare diseases (188)
Real estate (6238)
Regulatory (22263)
Research institute (2356)
Resumes & cover letters (358)
Southern California (1057)
Startups (3710)
United States (11487)
Vaccines (551)
Weight loss (169)
Date
Today (181)
Last 7 days (834)
Last 30 days (2938)
Last 365 days (36564)
2024 (30466)
2023 (40628)
2022 (51797)
2021 (56331)
2020 (54795)
2019 (47400)
2018 (35771)
2017 (33138)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (193)
Asia (39858)
Australia (6369)
California (2661)
Canada (1158)
China (210)
Colorado (115)
Connecticut (119)
Europe (84816)
Florida (379)
Georgia (96)
Illinois (313)
Indiana (183)
Kansas (95)
Maryland (511)
Massachusetts (2179)
Michigan (143)
Minnesota (247)
New Jersey (815)
New York (817)
North Carolina (672)
Northern California (1169)
Ohio (123)
Pennsylvania (738)
South America (1157)
Southern California (1057)
Texas (375)
Washington State (320)
702,366 Results for "tonix pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
October 29, 2024
·
4 min read
News
Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
October 25, 2024
·
4 min read
Pharm Country
Tonix Pharmaceuticals Announces Proposed Public Offering - June 26, 2024
Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company, announced that it intends to offer and sell shares of its common stock.
June 26, 2024
·
5 min read
Pharm Country
Tonix Pharmaceuticals Announces Proposed Public Offering - June 11, 2024
Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company, announced that it intends to offer and sell shares of its common stock.
June 11, 2024
·
5 min read
Deals
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - June 26, 2024
Tonix Pharmaceuticals Holding Corp. today announced that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
June 26, 2024
·
4 min read
Pharm Country
Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024
Tonix Pharmaceuticals Holding Corp. today announced data presented at an oral Keynote Talk at the Vaccine Congress 2024 held June 24-25, 2024 in Prague, Czech Republic.
June 25, 2024
·
8 min read
Pharm Country
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Jessica Morris, Chief Operating Officer, will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, Calif.
May 28, 2024
·
4 min read
Pharm Country
Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company, announced it has entered into a placement agency agreement for the purchase and sale of 3,753,558 shares of its common stock at an offering price of $1.065 per share.
June 12, 2024
·
5 min read
Press Releases
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
October 25, 2024
·
4 min read
Deals
Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split - June 6, 2024
Tonix Pharmaceuticals Holding Corp. today announced that it will effect a 1-for-32 reverse stock split of its outstanding common stock.
June 6, 2024
·
4 min read
1 of 70,237
Next
